comparemela.com

Latest Breaking News On - Investor relations legal affairs - Page 4 : comparemela.com

EDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023

Company to host conference call and webcast on Thursday, November 9th at 8:30am EDT LYON, France, October 26, 2023 EDAP TMS SA , the global leader in robotic energy-based therapies, today.

France
Ken-mobeck
Ryan-rhodes
John-fraunces
Blandine-confort
Investor-relations-legal-affairs
Company-contact
Lifesci-advisors
Edap-tms
Chief-executive-officer
Chief-financial-officer
Focal-one

EDAP Announces Second Quarter 2023 Financial Results

- Record second quarter and first half revenues of EUR 14.3 million and EUR 29.1 million , respectively - - Total HIFU Q2 2023 year-over-year revenue growth of 63.6% - - Strong Q2 2023.

Germany
London
City-of
United-kingdom
Japan
France
Switzerland
Zurich
Züsz
Austria
New-york
United-states

Form 6-K EDAP TMS SA For: Jun 30

Form 6-K EDAP TMS SA For: Jun 30
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

London
City-of
United-kingdom
Washington
United-states
Switzerland
Germany
Japan
France
Vaulx-en-velin
Rhôalpes
Zurich

EDAP Announces Reimbursement Approval in Switzerland for the Use of High-Intensity Focused Ultrasound (HIFU) in the Treatment of Prostate Cancer

LYON, France, July 26, 2023 EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it has received reimbursement approval in Switzerland for the use of High-Intensity Focused Ultrasound (HIFU) in the treatment of prostate cancer. This reimbursement took effect on July 1, 2023. "Receipt of appropriate reimbursement from the Swiss healthcare authorities is another acknowledgment of the growing, worldwide acceptance of HIFU as an eff

Austria
Germany
Zurich
Züsz
Switzerland
France
Swiss
Ryan-rhodes
Blandine-confort
Daniel-eberli
John-fraunces
Us-securities-exchange

EDAP TMS S A : Positive results from two studies reconfirm safety and efficacy of Focal One - Form 6-K

- Positive results from two studies reconfirm safety and efficacy of Focal One - - Company to host conference call and webcast today, Wednesday, May 17that 8:30 am EDT - . | May 17, 2023

Japan
Croix-rousse
Rhôalpes
France
Paris
France-general
French
Ken-mobeck
Ryan-rhodes
Gil-dubernard
John-fraunces
Blandine-confort

vimarsana © 2020. All Rights Reserved.